CORC  > 中南大学
Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)
Zhao, Shuiping; Wang, Yongjun; Mu, Yiming; Yu, Bilian; Ye, Ping; Yan, Xiaowei; Li, Zhanquan; Wei, Yidong; Ambegaonakr, Baishaili M.; Hu, Dayi*
刊名Atherosclerosis
2014
卷号235期号:2页码:463-469
关键词Cardiovascular diseases Dyslipidaemia Statin Lipid-lowering agents LDL cholesterol Non-HDL cholesterol
ISSN号0021-9150
DOI10.1016/j.atherosclerosis.2014.05.916
URL标识查看原文
WOS记录号WOS:000342411000932
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3317596
专题中南大学
作者单位1.[Yu, Bilian
2.Zhao, Shuiping] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha 410011, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Zhao, Shuiping,Wang, Yongjun,Mu, Yiming,et al. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)[J]. Atherosclerosis,2014,235(2):463-469.
APA Zhao, Shuiping.,Wang, Yongjun.,Mu, Yiming.,Yu, Bilian.,Ye, Ping.,...&Hu, Dayi*.(2014).Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS).Atherosclerosis,235(2),463-469.
MLA Zhao, Shuiping,et al."Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)".Atherosclerosis 235.2(2014):463-469.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace